These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9688446)

  • 1. Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies.
    Bow EJ
    J Antimicrob Chemother; 1998 Jun; 41 Suppl D():1-5. PubMed ID: 9688446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base.
    Preis S; Jürgens H; Friedland C; Oudekotte-David AA; Thomas L; Göbel U
    Klin Padiatr; 1993; 205(4):295-9. PubMed ID: 8377450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for febrile neutropenia during chemotherapy for HIV-related lymphoma.
    Park J; Kim TM; Hwang JH; Kim NH; Choe PG; Song KH; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
    J Korean Med Sci; 2012 Dec; 27(12):1468-71. PubMed ID: 23255844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in neutropenic cancer patients.
    Marchetti O; Calandra T
    Lancet; 2002 Mar; 359(9308):723-5. PubMed ID: 11888579
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia.
    Latiff Z; Zulkifli SZ; Jamal R
    Malays J Pathol; 2002 Dec; 24(2):83-9. PubMed ID: 12887165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile neutropenia in haematological malignancies.
    Sharma A; Lokeshwar N
    J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
    Ravaud A; Chevreau C; Cany L; Houyau P; Dohollou N; Roché H; Soubeyran P; Bonichon F; Mihura J; Eghbali H; Tabah I; Bui BN
    J Clin Oncol; 1998 Sep; 16(9):2930-6. PubMed ID: 9738560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing pattern of infection in neutropenic patients.
    Oppenheim BA
    J Antimicrob Chemother; 1998 Jun; 41 Suppl D():7-11. PubMed ID: 9688447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy.
    Hübel K; Engert A
    Onkologie; 2003 Feb; 26(1):73-9. PubMed ID: 12624522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.
    Crawford J; Dale DC; Lyman GH
    Cancer; 2004 Jan; 100(2):228-37. PubMed ID: 14716755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria parasitemia associated with febrile neutropenia in African patients undergoing chemotherapy for haematological malignancies. A report of three patients.
    Rapoport BL; Uys A
    Chemotherapy; 2008; 54(2):117-9. PubMed ID: 18303260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.
    Wang TY; Chen WM; Yang LY; Chen CY; Chou WC; Chen YY; Chen CC; Lee KD; Lu CH
    Support Care Cancer; 2016 Nov; 24(11):4697-703. PubMed ID: 27329415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study.
    Jolis L; Carabantes F; Pernas S; Cantos B; López A; Torres P; Funes C; Caballero D; Benedit P; Salar A;
    Eur J Cancer Care (Engl); 2013 Jul; 22(4):513-21. PubMed ID: 23730920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tips on the use of granulocyte colony-stimulating factors in cancer patients predisposed to chemotherapy - induced febrile neutropenia].
    Murakawa Y
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):693-6. PubMed ID: 23863645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fever and neutropenia: still a challenge.
    DiNubile MJ
    Contemp Intern Med; 1995 Jan; 7(1):35-7, 41-5. PubMed ID: 10150331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
    Aapro MS; Bohlius J; Cameron DA; Dal Lago L; Donnelly JP; Kearney N; Lyman GH; Pettengell R; Tjan-Heijnen VC; Walewski J; Weber DC; Zielinski C;
    Eur J Cancer; 2011 Jan; 47(1):8-32. PubMed ID: 21095116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
    Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
    N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.